FDA Clearance Tracker · P180029-S003
Lotus Edge Valve System
Last checked: Nov 20, 2026Latest source record: Dec 6, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Dec 6, 2019
Approved
Time to decision
197 days
Received May 23, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P180029-S003
- Device name
- Lotus Edge Valve System
- Applicant
- Boston Scientific Corporation
- Applicant location
- Marborough, MA
- Received
- May 23, 2019
- Decided
- Dec 6, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P180029
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval of the protocol for the Post Approval Study "RWU of LOTUS Edge Valve System."
Source documents
Other decisions for Boston Scientific Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.